Abstract
Despite currently effective means of diagnosis and treatment, gonorrhea remains a major public health problem throughout the world. In 1993, 439,673 cases of uncomplicated gonococcal infection were reported in the United States,(1) and an additional one to two unreported cases are believed to occur for each reported one. The complications of infection exact the greatest toll in terms of suffering and economic cost. Neisseria gonorrhoeae is a major cause of pelvic inflammatory disease, as well as associated infertility and ectopic pregnancies. Furthermore, gonorrhea may facilitate human immunodeficiency virus (HIV) transmission in some settings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Centers for Disease Control, Special focus: Surveillance for sexually transmitted diseases, Morbid. Mortal. Week. Rep. 42(SS3): 1–11 (1993).
Crede, K., Reports from the obstetrical clinic in Leipzig prevention of eye inflammation in the newborn, Arch. Gynaek. 17:50–53 (1881).
Weiss, P. J., Kennedy, C. A., McCann, D. F., Hill, H. E., and Oldfield, E. C., III, Fulminant endocarditis due to infection with penicillinase-producing Neisseria gonorrhoeae,Sex. Transm. Dis. 19:288–290 (1992).
Grimes, D. A., Deaths due to sexually transmitted diseases, J. Am. Med. Assoc. 255:1727–1729 (1986).
Centers for Disease Control, Case definition for public health surveillance, Morbid. Mortal. Week. Rep. 39(RR-13):1–43 (1990).
Centers for Disease Control, Sexually Transmitted Disease Surveillance, 1996, US Public Health Service, Atlanta, 1997.
Cronberg, S., The rise and fall of sexually transmitted diseases in Sweden, Genitourin. Med. 69:184–186 (1993).
Danielsson, D., Gonorrhea and syphilis in Sweden-Past and present, Scand. J. Infect. Dis. 69(Suppl.):69–76 (1990).
Treurniet, H. F., and Davidse, W., Sexually transmitted diseases reported by STD services in the Netherlands, 1984–1990, Genitourin. Med. 69:434–438 (1993).
Meyer, L., Goulet, V., and Massari, V., Surveillance of sexually transmitted diseases in France: Recent trends and incidence, Genitourin. Med. 70:15–21 (1994).
Rothenberg, R. B., The geography of gonorrhea, Am. J. Epidemiol. 117:688–694 (1983).
Centers for Disease Control, Sentinel surveillance system for antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae, Morbid. Mortal. Week. Rep. 36:585–593 (1987).
Anderson, J. E., McCormick, L., and Fichtner, R., Factors associated with self-reported STDs: Data from a national survey, Sex. Transm. Dis. 21:303–308 (1994).
Gale, J. L., and Hinds, M. W., Male urethritis in King County, Washington 1974–1975: 1. Incidence, Am. J. Public Health 68:20–25 (1978).
Eisenberg, M. S., and Wiesner, P. J., Reporting and treating gonorrhea: Results of a statewide survey in Alaska, J. Am. Venereal Dis. Assoc. 3:79–83 (1976).
Goodhart, M. E., Ogden, J., Zaidi, A. A., et al.,Factors affecting the performance of smear and culture tests for the detection of Neisseria gonorrhoeae, Sex. Transm. Dis. 9:63–69 (1982).
Knud-Hansen, C. R., Dallabetta, G. A., Reichart, C., Pabst, K. M., Hook, E. W., III, and Wasstheit, J. N., Surrogate methods to diagnose gonococcal and chlamydial cervicitis: Comparison of leukocyte esterase dipstick, endocervical Gram stain, and culture, Sex. Transm. Dis. 18:211–216 (1991).
McNagny, S. E., Parker, R. M., Zenilman, J. M., and Lewis, J. S., Urinary leukocyte esterase test: A screening method for the detection of asymptomatic chlamydial and gonococcal infections in men, J. Infect. Dis. 165:573–576 (1992).
Hale, Y. M., Melton, M. E., Lewis, J. S., and Willis, D. E., Evaluation of the PACE 2 Neisseria gonorrhoeae assay by three public health laboratories, J. Clin. Microbial. 31:451–453 (1993).
Panke, E. S., Yang, L. I., Leist, P. A., Magevney, P., Fry, R. J., and Lee, R. F., Comparison of Gen-probe DNA probe test and culture for the detection of Neisseria gonorrhoeae in endocervical specimens, J. Clin. Microbial. 29:883–888 (1991).
Lewis, J. S., Fakile, O., Foss, E., Legarza, G., Lowe, K., and Powning, D., Direct DNA probe assay for Neisseria gonorrhoeae in pharyngeal and rectal specimens, J. Clin. Microbiol. 31:2783–2785 (1993).
Chapin-Robertson, K., Use of molecular diagnostics in sexually transmitted diseases, Diagn. Microbiol. Infect. Dis. 16:173–184 (1993).
Birkenmeyer, L., and Armstrong, A. S., Preliminary evaluation of the ligase chain reaction for specific detection of Neisseria gonorrhoeae, J. Clin. Microbiol. 30:3089–3094 (1992).
Brooks, G. F., and Lammel, C. J., Humoral immune response to gonococcal infections, Clin. Microbiol. Rev. 2(Suppl.):S5–S10 (1989).
McGee, Z. A., Johnson, A. P., and Taylor-Robinson, D., Pathogenic mechanisms of Neisseria gonorrhoeae: Observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4, J. Infect. Dis. 143:413–422 (1981).
Young, J. D. E., Blake, M., Mauro, A., and Cohn, Z. A., Properties of the major outer membrane protein from Neisseria gonorrhoeae incorporated into model lipid membranes, Proc. Natl. Acad. Sci. USA 80:3831–3835 (1983).
Knapp, J. S., Tam, M. R., Nowinski, R. C., Holme, K. K., and Sandstrom, E. G., Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I, J. Infect. Dis. 150:44–48 (1984).
Sparling, P. F., Cannon, J. G., and So, M., Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae, J. Infect. Dis. 153:196–201 (1986).
Joiner, K. A., Scales, R., Warren, K. A., Frank, M. M., and Rice, P. A., Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae, J. Clin. Invest. 76:1765–1772 (1985).
Plummer, F. A., Chubb, H., Simonsen, J. N., Bosire, M., Slaney, L., MacLean, J., Ndinya-Achola, J. D., Waiyaki, P., and Burnham, R. C. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection, J. Clin. Invest. 91:339–343 (1993).
van Putten, J. P. M., Iron acquisition and the pathogenesis of meningococcal and gonococcal disease, Med. Microbiol. Immunol. 179:289–295 (1990).
McKenna, W. R., Mickelsen, P. A., Sparling, P. F., and Dyer, D. W., Iron uptake from lactoferrin and transferrin by Neisseria gonorrhoeae,Infect. Immun. 56:578–791 (1988).
Handsfield, H. H., Lipman, T. O., Harnisch, J. P., Tronca, E., and Holmes, K. K., Asymptomatic gonorrhea in men, N. Engl. J. Med. 290:117–123 (1974).
Allard, R., Robert, J., Turgeon, P., and LePage, Y., Predictors of asymptomatic gonorrhea among patients seen by private practitioners, Can. Med. Assoc. J. 133:1135–1146 (1985).
Holmes, K. K., Johnson, D. W., and Trostle, H. J., An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females, Am. J. Epidemiol. 91:17–24 (1970).
Robertson, P., and Schachter, J., Failure to identify venereal disease in a lesbian population, Sex. Transm. Dis. 8:75–76 (1981).
Ostrow, D. G., and Altman, N. L., Sexually transmitted diseases and homosexuality, Sex. Transm. Dis. 10:208–215 (1983).
Schwarcz, S. K., Bolan, G. A., Fullilove, M., McCright, J., Fullilove, R., Kohn, R., and Rolfs, R. T., Crack cocaine and the exchange of sex for money or drugs, Sex. Transm. Dis. 19:7–12 (1992).
May, R. M., The transmission and control of gonorrhea, Nature 291:376–377 (1981).
Garnet, G. P., and Anderson, R. M., Contact tracing and the estimation of sexual mixing patterns: The epidemiology of gonococcal infections, Sex. Transm. Dis. 20:181–191 (1993).
Rothenberg, R. B., The geography of gonorrhea, Am. J. Epidemiol. 117:688–694 (1983).
Jaffe, H. W., Zaidi, A. A., Thomsberry, C., Reynolds, G. H., and Wiesner, P. J., Trends and seasonality of antibiotic resistance of Neisseria gonorrhoeae, J. Infect. Dis. 136:684–688 (1977).
Ross, J. D. C., and Scott, G. R., Seasonal variation in gonorrhea, Eur. J. Epidemiol. 8:252–255 (1992).
de Wit, J. B. F., Van den Hoek, J. A. R., Sandfort, T. G. M., et al. Increase in unprotected anogenital intercourse among homosexual men, Am. J. Public Health 83:1451–1453 (1993).
Sherrard, J., and Forsyth, J. R. L., Homosexually acquired gonorrhea in Victoria, 1983–1991, Med. J. Australia 158:450–453 (1993).
Evans, B. G., Catchpole, M. A., Heptonstall, J., Mortimer, J. Y., McCarringle, C. A., Nicoll, A. G., Wright, P., Gill, O. N., and Swan, A. V., Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales, Br. Med. J. 306: 426–428 (1993).
Piot, P., and Laga, M., Genital ulcers, other sexually transmitted diseases, and the sexual transmission of HIV, Br. Med. J. 298: 623–624 (1989).
Laga, M., Manoka, A., Kivuvu, M., Malele, B., Tuliza, M., Nzila, N., Goeman, J., Behets, F., Batter, V., and Alary, M., Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study, AIDS 7:95102 (1993).
Weir, S. S., Feldblum, P. J., Roddy, R. E., and Zekeng, L., Gonorrhea as a risk factor for HIV acquisition, AIDS 8:1605–1608 (1994).
Lau, R. K., Goh, B. T., Estreich, S., Cox, S. N., and Levy, I., Adult gonococcal keratoconjunctivitis with AIDS, Br. J. Ophthalmol. 74:52 (1990).
Faruki, H., Kohmescher, R. N., McKinney, W. P., and Sparling, P. F., A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance), N. Engl. J. Med. 313:607–611 (1985).
Sherrard, J., and Barlow, D., PPNG at St. Thomas’ Hospital-A changing provenance, Int. J. STD AIDS 4:330–332 (1993).
The Australian Gonococcal Surveillance Program, The incidence of gonorrhea and the antibiotic sensitivity of gonococci in Australia, 1981–1991, Genitourin. Med. 69:364–369 (1993).
Otubo, J. A. M., Imade, G. E., Sagay, A. S., and Towobola, O. A., Resistance of recent Neisseria gonorrhoeae isolates in Nigeria and outcome of single-dose treatment with ciprofloxacin, Infection 20:339–341 (1992).
Clendennen, T. E., Echeverria, P., Saengeur, S., Kees, E. S., Boskeys, J. W., and Wignall, F. S., Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand, Antimicrob. Agents Chemother. 36:1682–1687 (1992).
Boslego, J. W., Tramont, E. C., Takafuji, E. T., Diniega, B. M., Mitchell, B. S., Small, J. W., Khan, W. N., and Stein, D. C., Effect of spectinomycin use on the prevalence of spectinomycinresistant and of penicillinase-producing Neisseria gonorrhoeae,N. Engl. J. Med. 317:272–278 (1987).
Zenilman, J. M., Nims, L. J., Menegus, M. A., Nolte, F., and Knapp, J. S., Spectinomycin-resistant gonococcal infections in the United States, 1985–1986, J. Infect. Dis. 156:1002–1004 (1987).
Kam, K., Lo, K., Lai, C., Lee, Y. S., and Chen, C. B., Ofloxacin susceptibilities of 5,667 Neisseria gonorrhoeae strains isolated in Hong Kong, Antimicrob. Agents. Chemother. 37:2007–2008 (1993).
Tapsall, J. W., Shultz, T. R., and Phillips, E. A., Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to quinolone antibiotics, Pathology 24:27–31 (1992).
Bogaerts, J., Tello, W. M., Akingeneye, J., Mukantabara, V., Van Dyck, E., and Piot, P., Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhea and decrease of in vitro susceptibility to quinolones over time in Rwanda, Genitourin. Med. 69:196–200 (1993).
Centers for Disease Control, Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones-Ohio and Hawaii, 1992–1994, Morbid. Mortal. Week. Rep. 43:325–327 (1994).
Gilbaugh, J. H., and Fuchs, P. C., The gonococcus and the toilet seat, N. Engl. J. Med. 301:91–93 (1979).
Sgroi, S. M., Pediatric gonorrhea and child sexual abuse: The venereal disease connection, Sex. Transm. Dis. 9:154–156 (1982).
Ross, S. C., and Densen, P., Complement deficiency state and infection: Epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency, Medicine 63:243–272 (1984).
Tramont, E. C., Inhibition of adherence of Neisseria gonorrhoeae by human genital secretions, J. Clin. Invest. 59:117–124 (1977).
Kearns, D. H., O’Reilly, R. J., Lee, R. J., and Welch, B. A., Secretory IgA antibodies in the urethral exudate of men with uncomplicated urethritis due to Neisseria gonorrhoeae, J. Infect. Dis. 127:99–101 (1973).
Ison, C. A., Hadfield, S. G., Bellinger, C. M., Dawson, S. A., and Glynn, A. A., The specificity of serum and local antibodies in female gonorrhea, Clin. Exp. Immunol. 65:198–205 (1986).
Meyer, T. F., and van Putten, J. P. M., Genetic mechanisms and biological implications of phase variation in pathogenic Neisseriae, Clin. Microbiol. Rev. 2(Suppl.):S139–S145 (1989).
Sarafian, S. K., Tam, M. R., and Morse, S. A., Gonococcal protein I-specific opsonic IgG in normal human serum, J. Infect. Dis. 148: 1025–1032 (1983).
Hooten, T. M., and Barnes, R. C., Urethritis in men, Infect. Dis. Clin. North Am. 1:165–178 (1987).
Platt, R., Rice, P. A., and McCormack, W. M., Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea, J. Am. Med. Assoc. 250: 3205–3209 (1983).
Centers for Disease Control, Pelvic inflammatory disease: Guidelines for prevention and management, Morbid. Mortal. Week. Rep. 40(RR-5):1–25 (1991).
Westrom, L., and Wolner-Hanssen, P., Pathogenesis of pelvic inflammatory disease, Genitourin. Med. 69:9–17 (1993).
Westrom, L., Incidence, prevalence, and trends of acute pelvic inflammatory diseases and its consequences in industrialized countries, Am. J. Obstet. Gynecol. 138:880–892 (1980).
Westrom, L., Joesoef, R., Reynolds, G., Hagdu, A., and Thompson, S. E., Pelvic inflammatory disease and fertility, Sex. Transm. Dis. 19:185–191 (1992).
Hillis, S. D., Joesoef, R., Marchbanks, P. A., Wasserheit, J. N., Cates, W., Jr., and Westrom, L., Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility, Am. J. Obstet. Gynecol. 168:1503–1509 (1993).
Sweet, R. L., Pelvic inflammatory disease and infertility in women, Infect. Dis. Clin. North Am. 1:199–215 (1987).
Stacey, C. M., Munday, P. E., Taylor-Robinson, D., et al.,A longitudinal study of pelvic inflammatory disease, Br. J. Obstet. Gynaecol. 99:994–999 (1992).
Jacobson, L., and Westrom, L., Objectivized diagnosis of pelvic inflammatory disease, Am. J.Obstet. Gynecol. 105:1088–1098 (1969).
Peterson, H. B., Walker, C. K., Kahn, J. G., Washington, A. E., Eschenbach, D. A., and Faro, S., Pelvic inflammatory disease, J. Am. Med. Assoc. 266:2605–2611, (1991).
Walker, C. K., Kahn, J. G., Washington, A. E., Peterson, H. B., and Sweet, R. L., Pelvic inflammatory disease: Meta-analysis of antimicrobial regimen efficacy, J. Infect. Dis. 168:969–978 (1993).
Klein, E. J., Fisher, L. S., Chow, A. W., and Guze, L. B., Anorectal gonorrheal infection, Ann. Intern. Med. 86:340–346 (1977).
Lebedoff, D. A., Hochman, E. B., Rectal gonorrhea in men: Diagnosis and treatment, Ann. Intern. Med. 92:463–466 (1980).
Quinn, T. C., Stamm, W. E., Goodell, S. E., Mkrtichian, E., Benedetti, J., Corey, L., Schuffler, M. D., and Holmes, K. K., The polymicrobial origin of intestinal infection in homosexual men, N. Engl. J. Med. 309:576–582 (1983).
Law, C., Sexually transmitted diseases and enteric infections in the male homosexual population, Semin. Dermatol. 9:178–184 (1990).
Wiesner, P. J., Tronca, E., Bonin, P., Pedersen, A. H., and Holmes, K. K., Clinical spectrum of pharyngeal gonococcal infection, N. Eng1. J. Med. 284:181–185 (1973).
Hutt, D. M., and Judson, F. M., Epidemiology and treatment of oropharyngeal gonorrhea, Ann. Intern. Med. 104:655–658 (1986).
Judson, E. N., Ehret, J. M., and Handsfield, H. H., Comparative study of certriaxone and spectinomycin for treatment of pharyngeal and anorectal gonorrhea, J. Am. Med. Assoc. 253:1417–1419 (1985).
Wiesner, P. J., Handsfield, H. H., and Holmes, K. K., Low antibiotic resistance of gonococci causing disseminated infection, N. Engl. J. Med. 288:1221–1226 (1973).
Wise, C. M., Morris, C. R., Wasilauskas, B. L., and Salzer, W. L., Gonococcal arthritis in an era of increasing penicillin resistance, Arch. Intern. Med. 154:2690–2695 (1994).
Koss, P. J., Disseminated gonococcal infection-The tenosynovitis-dermatitis and suppurative arthritis syndromes, Clev. Clin. Q. 52:161–173 (1985).
Masi, A. T., and Eisenstein, B. I., Disseminated gonococcal infection and gonococcal arthritis: II. Clinical manifestations, diagnosis, complications, treatment, and prevention, Semin. Arthritis Rheum. 10:173–197 (1981).
O’Brien, J. P., Goldenberg, D. L., and Rice, P. A., Disseminated gonococcal infection: A prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms, Medicine 62:395–406 (1983).
Ullman, S., Roussel, T. J., Culbertson, W. W., Forster, R. K., Alfonso, E., Mendelsohn, A. D., Herdemann, D. A., and Holland, S. P., Neisseria gonorrhoeae keratoconjunctivitis, Ophthalmology 94:525–531 (1987).
Wan, W. L., Farkas, G. C., May, W. N., and Robin, J. B., Theclinical characteristics and course of adult gonococcal conjunctivitis, Am. J. Ophthalmol. 102:575–583 (1986).
Fransen, L., Nsanze, H., Klauss, V., Van der Stuyft, P., D’Costa, L., Brunham, R. C., and Piot, P., Ophthalmia neonatorum in Nairobi, Kenya: The roles of Neisseria gonorrhoeae and Chlamydia trachomatis,J. Infect. Dis. 153:862–869 (1986).
Laga, M., Meheus, A., and Piot, P., Epidemiology and control of gonococcal ophthalmia neonatorum, Bull. WHO 67:471–478 (1989).
Alfonso, E., Friedland, B., Hupp, S., Olsen, K., Senikowich, K., Sklar, V. E., and Forster, R. K., Neisseria gonorrhoeae conjunctivitis. An outbreak during an epidemic of acute hemorrhagic conjunctivitis, J. Am. Med. Assoc. 250:794–795 (1983).
Spark, R. P., Dahlberg, P. W., and LaBelle, J. W., Pseudogonococcal ophthalmia neonatorum, Am. J. Clin. Pathol. 72:471–473 (1979).
Nenstein, L., Goldenring, J., and Carpenter, S., Nonsexual transmission of sexually transmitted diseases: An infrequent occurrence, Pediatrics 74:67–76 (1984).
Potterat, J. J., Markewich, G. S., and Rothenberg, R., Prepubertal infection with Neisseria gonorrhoeae: Clinical and epidemiologic significance, Sex. Transm. Dis. 5:1–3 (1978).
Whittington, W. L., Rice, R. J., Biddle, J. W., and Knapp, J. S., Incorrect identification of Neisseria gonorrhoeae from infants and children, Pediatr. Infect. Dis. J. 7:3–10 (1988).
Condoms for prevention of sexually transmitted diseases, Morbid. Mortal. Week. Rep. 37:133–137 (1988).
Stone, K. A., Grimes, D. A., and Magder, L. S., Personal protection against sexually transmitted diseases, Am. J. Obstet. Gynecol. 155:180–188 (1986).
Niruthisard, S., Roddy, R. E., and Chutivongse, S., Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections, Lancet 1:1371–1375 (1992).
Bradbeer, C. S., Thin, R. N., Tan, T., and Thirumoorthy, T., Prophylaxis against infection in Singaporean prostitutes, Genitourin. Med. 64:52–53 (1988).
Loveless, J. A., and Denton, W., The oral use of sulfathiazole as a prophylaxis for gonorrhea, J. Am. Med. Assoc. 121:827–828 (1943).
Eagle, H., Gude, A. V., Beckman, G. E., et al., Prevention of gonorrhea with penicillin tablets, J. Am. Med. Assoc. 140:940–943 (1949).
Harrison, W. O., Hooper, R. R., Wiesner, P. J., Campbell, A. F., Karney, W. W., Reynolds, G. W., Jones, O. A., and Holmes, K. K., A trial of minocycline given after exposure to prevent gonorrhea, N. Engl. J. Med. 300:1074–1078 (1979).
Tramont, E. C., Gonococcal vaccines, Clin. Microbiol. Rev. 2(Suppl.):S74–S77 (1989).
Suggested Reading
Zenilman, J. M., Gonorrhea: Clinical and public health issues, Hosp. Pract. (Off. Ed.) 28(2A):29–45 (1993).
Moran, J. S., Treating uncomplicated Neisseria gonorrhoeae infections: Is the anatomic site of infection important? Sex. Trans. Dis. 22:39–47 (1995).
Cohen, M. S., and Sparling, P. F., Mucosal infection with Neisseria gonorrhoeae: Bacterial adaptation and mucosal defenses, J. Clin. Invest. 89:1699–1705 (1992).
Updated sexually transmitted disease incidence data and treatment protocols are available from the CDC via the Internet at http://www.cdc.gov.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
De Maio, J., Zenilman, J. (1998). Gonococcal Infections. In: Evans, A.S., Brachman, P.S. (eds) Bacterial Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5327-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5327-4_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45323-6
Online ISBN: 978-1-4615-5327-4
eBook Packages: Springer Book Archive